Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sameer A Parikh

Showing results (71-80 of 182) with videos related to

Pageof 19
Sort By:
Haematologica|April 24, 2024
Monocyte response to SARS-CoV-2 protein ORF8 is associated with severe COVID-19 infection in patients with chronic lymphocytic leukemiaGordon J Ruan, Xiaosheng Wu, Kimberly A Gwin, et al.
Leukemia & Lymphoma|December 12, 2022
Time to second treatment can be used to predict overall survival in chronic lymphocytic leukemia: identifying risk factors to help guide treatment selectionKurt S Bantilan, Neil E Kay, Sameer A Parikh, et al.
Blood Cancer Journal|February 19, 2021
Upregulation of AXL and β-catenin in chronic lymphocytic leukemia cells cultured with bone marrow stroma cells is associated with enhanced drug resistanceSutapa Sinha, Charla R Secreto, Justin C Boysen, et al.
Blood Advances|September 18, 2020
Incidental Richter transformation in chronic lymphocytic leukemia patients during temporary interruption of ibrutinibPaul J Hampel, Hua-Jay J Cherng, Timothy G Call, et al.
Haematologica|April 21, 2019
Clinicopathological features, treatment approaches, and outcomes in Rosai-Dorfman diseaseGaurav Goyal, Aishwarya Ravindran, Jason R Young, et al.
Blood Neoplasia|June 2, 2025
Aberrant heterochromatin silences immune response genes in chronic lymphocytic leukemiaOlivia M Depies, Qianqian Guo, Yuan Gao, et al.
Blood Advances|April 25, 2019
Characterization of a cryptic <i>IGH/CCND1</i> rearrangement in a case of mantle cell lymphoma with negative <i>CCND1</i> FISH studiesJess F Peterson, Linda B Baughn, Rhett P Ketterling, et al.
Ejhaem|October 17, 2024
Medical history and lifestyle factors have limited impact on time-to-first-treatment in patients with chronic lymphocytic leukemiaIngrid Glimelius, Geffen Kleinstern, Dennis P Robinson, et al.
British Journal of Haematology|July 12, 2013
Diffuse large B-cell lymphoma (Richter syndrome) in patients with chronic lymphocytic leukaemia (CLL): a cohort study of newly diagnosed patientsSameer A Parikh, Kari G Rabe, Timothy G Call, et al.
Blood|March 7, 2015
The efficacy of ibrutinib in the treatment of Richter syndromeMazie Tsang, Tait D Shanafelt, Timothy G Call, et al.
Pageof 19

Showing results (71-80 of 182) with videos related to

Sort By:
Pageof 19
Haematologica|April 24, 2024
Monocyte response to SARS-CoV-2 protein ORF8 is associated with severe COVID-19 infection in patients with chronic lymphocytic leukemiaGordon J Ruan, Xiaosheng Wu, Kimberly A Gwin, et al.
Leukemia & Lymphoma|December 12, 2022
Time to second treatment can be used to predict overall survival in chronic lymphocytic leukemia: identifying risk factors to help guide treatment selectionKurt S Bantilan, Neil E Kay, Sameer A Parikh, et al.
Blood Cancer Journal|February 19, 2021
Upregulation of AXL and β-catenin in chronic lymphocytic leukemia cells cultured with bone marrow stroma cells is associated with enhanced drug resistanceSutapa Sinha, Charla R Secreto, Justin C Boysen, et al.
Blood Advances|September 18, 2020
Incidental Richter transformation in chronic lymphocytic leukemia patients during temporary interruption of ibrutinibPaul J Hampel, Hua-Jay J Cherng, Timothy G Call, et al.
Haematologica|April 21, 2019
Clinicopathological features, treatment approaches, and outcomes in Rosai-Dorfman diseaseGaurav Goyal, Aishwarya Ravindran, Jason R Young, et al.
Blood Neoplasia|June 2, 2025
Aberrant heterochromatin silences immune response genes in chronic lymphocytic leukemiaOlivia M Depies, Qianqian Guo, Yuan Gao, et al.
Blood Advances|April 25, 2019
Characterization of a cryptic <i>IGH/CCND1</i> rearrangement in a case of mantle cell lymphoma with negative <i>CCND1</i> FISH studiesJess F Peterson, Linda B Baughn, Rhett P Ketterling, et al.
Ejhaem|October 17, 2024
Medical history and lifestyle factors have limited impact on time-to-first-treatment in patients with chronic lymphocytic leukemiaIngrid Glimelius, Geffen Kleinstern, Dennis P Robinson, et al.
British Journal of Haematology|July 12, 2013
Diffuse large B-cell lymphoma (Richter syndrome) in patients with chronic lymphocytic leukaemia (CLL): a cohort study of newly diagnosed patientsSameer A Parikh, Kari G Rabe, Timothy G Call, et al.
Blood|March 7, 2015
The efficacy of ibrutinib in the treatment of Richter syndromeMazie Tsang, Tait D Shanafelt, Timothy G Call, et al.
Pageof 19